FCM

Farallon Capital Management Portfolio holdings

AUM $15.3B
1-Year Est. Return 51.42%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+51.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.3B
AUM Growth
-$2.87B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
201
New
Increased
Reduced
Closed

Top Buys

1
+$292M
2
+$280M
3
+$248M
4
MA icon
Mastercard
MA
+$138M
5
TMO icon
Thermo Fisher Scientific
TMO
+$133M

Top Sells

1
+$650M
2
+$470M
3
+$334M
4
NDAQ icon
Nasdaq
NDAQ
+$290M
5
RNAM
Avidity Biosciences
RNAM
+$233M

Sector Composition

1 Healthcare 57.82%
2 Financials 13.96%
3 Technology 12.78%
4 Consumer Discretionary 5.83%
5 Industrials 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HQY icon
126
HealthEquity
HQY
$7.39B
$234K ﹤0.01%
2,800
-2,200
SNDX icon
127
Syndax Pharmaceuticals
SNDX
$1.63B
$234K ﹤0.01%
10,000
FOLD
128
DELISTED
Amicus Therapeutics
FOLD
$231K ﹤0.01%
16,000
QURE icon
129
uniQure
QURE
$1.88B
$229K ﹤0.01%
14,000
BCRX icon
130
BioCryst Pharmaceuticals
BCRX
$2.12B
$228K ﹤0.01%
24,000
VCYT icon
131
Veracyte
VCYT
$3.89B
$225K ﹤0.01%
7,000
GRFS icon
132
Grifois
GRFS
$5.08B
$225K ﹤0.01%
28,000
ABVX
133
Abivax
ABVX
$7.18B
$223K ﹤0.01%
2,000
-385,000
GEHC icon
134
GE HealthCare
GEHC
$28.2B
$214K ﹤0.01%
3,000
RVMDW icon
135
Revolution Medicines Inc Warrant
RVMDW
$69.1M
$209K ﹤0.01%
120,085
HIMS icon
136
Hims & Hers Health
HIMS
$6.37B
$208K ﹤0.01%
10,000
-3,376,986
BLTE
137
Belite Bio
BLTE
$5.41B
$207K ﹤0.01%
+1,300
MMSI icon
138
Merit Medical Systems
MMSI
$3.63B
$207K ﹤0.01%
3,000
SUPN icon
139
Supernus Pharmaceuticals
SUPN
$2.56B
$207K ﹤0.01%
+4,000
HR icon
140
Healthcare Realty
HR
$6.8B
$204K ﹤0.01%
12,000
URGN icon
141
UroGen Pharma
URGN
$1.29B
$198K ﹤0.01%
11,000
VIR icon
142
Vir Biotechnology
VIR
$1.48B
$197K ﹤0.01%
+22,000
PGEN icon
143
Precigen
PGEN
$1.38B
$194K ﹤0.01%
50,000
SDGR icon
144
Schrodinger
SDGR
$1.12B
$193K ﹤0.01%
17,000
-54,000
DYN icon
145
Dyne Therapeutics
DYN
$2.85B
$181K ﹤0.01%
10,000
NVAX icon
146
Novavax
NVAX
$1.68B
$179K ﹤0.01%
22,000
-173,000
PACB icon
147
Pacific Biosciences
PACB
$491M
$178K ﹤0.01%
135,000
SLS icon
148
SELLAS Life Sciences
SLS
$1.52B
$169K ﹤0.01%
+40,000
ADPT icon
149
Adaptive Biotechnologies
ADPT
$2.42B
$153K ﹤0.01%
11,000
OCUL icon
150
Ocular Therapeutix
OCUL
$1.83B
$152K ﹤0.01%
18,000
4 5
6
7 8